Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-06-19

Clinical Trial Update: Treatment of Patients Suffering From Nervous Restlessness With PASCOFLAIR®

View source ↗

Summary

A completed clinical trial evaluating PASCOFLAIR for nervous restlessness has posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PASCOFLAIR (Passiflora incarnata extract)

Snippet

Sponsor: Pascoe Pharmazeutische Praeparate GmbH | Conditions: Nervous Restlessness | Status: COMPLETED | Results posted: 2017-06-19